Global airway disease: mepolizumab simultaneously improves outcomes in severe CRSwNP and asthma. Mullol J, Backer V, Constantinidis J, Eguiluz-Gracia I, et al. Rhinology 2025;63:113-115.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Mullol J, Backer V, Constantinidis J, Eguiluz-Gracia I, et al. Global airway disease: mepolizumab simultaneously improves outcomes in severe CRSwNP and asthma. Rhinology 2025;63:113-115.
PMID: 39660637